12:00 AM
 | 
Sep 29, 2008
 |  BC Week In Review  |  Clinical News  |  Regulatory

Pradaxa dabigatran etexilate regulatory update

U.K.'s NICE issued final guidance recommending Pradaxa dabigatran etexilate from Boehringer Ingelheim for its approved indication of preventing...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >